JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,497,978 | -17.8% | 148,609 | -3.1% | 0.00% | – |
| Q2 2023 | $1,821,286 | +16.2% | 153,436 | +18.3% | 0.00% | – |
| Q1 2023 | $1,568,000 | +114687.7% | 129,657 | +24.9% | 0.00% | – |
| Q4 2022 | $1,366 | -99.9% | 103,783 | -1.2% | 0.00% | – |
| Q3 2022 | $1,422,000 | +12.5% | 105,053 | +1.5% | 0.00% | – |
| Q2 2022 | $1,264,000 | +393.8% | 103,478 | +477.3% | 0.00% | – |
| Q1 2022 | $256,000 | -2.3% | 17,926 | +34.9% | 0.00% | – |
| Q4 2021 | $262,000 | +87.1% | 13,288 | +105.3% | 0.00% | – |
| Q3 2021 | $140,000 | +775.0% | 6,474 | +902.2% | 0.00% | – |
| Q2 2021 | $16,000 | – | 646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |